Tuesday, October 9, 2012

Google Alert - pharmaceutical news

News6 new results for pharmaceutical news
 
Savient Pharmaceuticals' Impressive Run May Continue Higher
Reuters
Promoted and established CEO Louis Ferrari who brings over 30 years of experience in the pharmaceutical industry, including expertise in product launches, new product development, international marketing, sales management, and sales training.
See all stories on this topic »
Pharmaceutical companies seek global solutions
China Daily
Thierry Bernard doesn't need to be convinced of the quality of China's healthcare industry. But the vice-president of commercial operations, worldwide sales, marketing and customer service at the French company bioMerieux, says there is still ...
See all stories on this topic »
Tessenderlo Group has the intention to sell its pharmaceutical ingredients ...
Reuters
Tessenderlo Group (NYSE Euronext: TESB) announced today that it has the intention to sell its pharmaceutical ingredients activities, Farchemia and Calaire Chimie, to International Chemical Investors Group (ICIG), a private industrial holding company.
See all stories on this topic »
Aquavit Pharmaceuticals and Uniquest sign MOU for Alliance Partnership
Sacramento Bee
This Alliance Partnership represents a key commitment to realize Aquavit Pharmaceuticals' cutting-edge technology within the context of Uniquest's advanced engineering and production capabilities. The medical device industry is primed for accelerated ...
See all stories on this topic »
DGAP-News: Astex Pharmaceuticals Earns $5 Million for First Commercial Sale ...
Equities.com
DGAP Astex Pharmaceuticals, Inc. 09.10.2012 12:00 --------------------------------------------------------------------------- DUBLIN, Calif., 2012-10-09 12:00 CEST (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company ...
See all stories on this topic »
Future of Pharmaceutical R&D Requires Innovative Dosage Formulations ...
Equities.com
A survey of 500 pharmaceutical industry influencers reveals that four out of five surveyed (82%) believe innovative dosage form technologies are required to meet the needs of today's pharmaceutical research and development challenges. Three-quarters ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

0 comments:

Post a Comment

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost